NASDAQ:OGI Organigram - OGI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.91 0.00 (-0.29%) (As of 02/1/2023 10:32 AM ET) Add Compare Share Share Today's Range$0.90▼$0.9250-Day Range$0.70▼$1.1952-Week Range$0.70▼$1.87Volume153,608 shsAverage Volume1.29 million shsMarket Capitalization$284.48 millionP/E RatioN/ADividend YieldN/APrice Target$1.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Organigram MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside83.4% Upside$1.67 Price TargetShort InterestHealthy1.97% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.40Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.05) to ($0.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.16 out of 5 starsMedical Sector468th out of 1,053 stocksPharmaceutical Preparations Industry233rd out of 519 stocks 3.5 Analyst's Opinion Consensus RatingOrganigram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.67, Organigram has a forecasted upside of 83.4% from its current price of $0.91.Amount of Analyst CoverageOrganigram has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.97% of the outstanding shares of Organigram have been sold short.Short Interest Ratio / Days to CoverOrganigram has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Organigram has recently decreased by 16.96%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 2.4 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Organigram this week, compared to 1 article on an average week.Search Interest17 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 42% compared to the previous 30 days.MarketBeat FollowsOnly 12 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram is held by insiders.Percentage Held by InstitutionsOnly 10.98% of the stock of Organigram is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Organigram are expected to grow in the coming year, from ($0.05) to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -30.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -30.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Organigram (NASDAQ:OGI) StockOrganigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.Read More Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Stock News HeadlinesJanuary 4, 2023 | marketbeat.comMarketBeat: Week in Review 11/28 – 12/02 (OGI)Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this weekJanuary 30, 2023 | reuters.comOGI.TO - | Stock Price & Latest News | ReutersFebruary 1, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 30, 2023 | americanbankingnews.comOrganigram Holdings Inc. (NASDAQ:OGI) Sees Significant Decrease in Short InterestJanuary 26, 2023 | finance.yahoo.comOrganigram Provides NASDAQ Listing UpdateJanuary 13, 2023 | benzinga.comWhat Holds Value For Canadian Cannabis Company Organigram? Analyst OpinesJanuary 12, 2023 | finance.yahoo.comOrganiGram (OGI) Reports Q1 Loss, Misses Revenue EstimatesJanuary 12, 2023 | finance.yahoo.comOrganigram Reports Record First Quarter Fiscal 2023 ResultsFebruary 1, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 3, 2023 | finance.yahoo.comOrganiGram (OGI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?December 16, 2022 | finance.yahoo.comOrganigram Holdings Inc. (NASDAQ:OGI) Q4 2022 Earnings Call TranscriptDecember 9, 2022 | ca.finance.yahoo.comStocks in play: Organigram Holdings Inc.November 28, 2022 | finance.yahoo.comOrganigram Reports Record Fourth Quarter and Full Year Fiscal 2022 ResultsNovember 23, 2022 | finance.yahoo.comOrganigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash CategoriesOctober 16, 2022 | finance.yahoo.comThe past three years for OrganiGram Holdings (TSE:OGI) investors has not been profitableOctober 13, 2022 | fool.com2 Pot Stocks That Could Set You Up for Life - The Motley FoolOctober 12, 2022 | nasdaq.comTilray Brands Stock Could Grow by 20 Times by 2030 - NasdaqOctober 6, 2022 | fool.comWhy Pot Stocks Like Canopy Growth and Organigram Surged Higher Today - The Motley FoolSeptember 15, 2022 | fool.com1 Surprising Stat That Could Help Jump-Start This Struggling Sector - The Motley FoolSeptember 14, 2022 | benzinga.comOrganiGram Holdings (NASDAQ:OGI), HEXO (NASDAQ:HEXO) – Want Exposure To The Canadian Recreational Cannabi - BenzingaSeptember 14, 2022 | seekingalpha.comNew congressional bill aims to empower small cannabis growers (NASDAQ:TLRY) - Seeking AlphaSeptember 8, 2022 | marketwatch.comQuebec and Alberta provinces reportedly won't allow sales of Mike Tyson's cannabis by Hexo - MarketWatchSeptember 1, 2022 | fool.comWhy Pot Stocks Are Going Up In Smoke Today - The Motley FoolAugust 31, 2022 | streetinsider.comCanadian Cannabis Stocks To Watch In September - StreetInsider.comAugust 18, 2022 | nasdaq.comOrganigram Holdings Inc. Common Shares (OGI)July 27, 2022 | streetinsider.comTop Canadian Cannabis Stocks To Watch Before August - StreetInsider.comJuly 14, 2022 | fool.comHere's What Moved Sundial Growers, Organigram, and Canopy Growth Stocks Today - The Motley FoolSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Company Calendar Last Earnings11/28/2022Today2/01/2023Next Earnings (Estimated)4/11/2023Fiscal Year End8/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:OGI CUSIPN/A CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees841Year FoundedN/APrice Target and Rating Average Stock Price Forecast$1.67 High Stock Price Forecast$2.00 Low Stock Price Forecast$1.50 Forecasted Upside/Downside+83.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,230,000.00 Net Margins-4.97% Pretax Margin-5.41% Return on Equity-6.00% Return on Assets-5.30% Debt Debt-to-Equity RatioN/A Current Ratio4.71 Quick Ratio2.84 Sales & Book Value Annual Sales$111.27 million Price / Sales2.56 Cash FlowN/A Price / Cash FlowN/A Book Value$1.22 per share Price / Book0.74Miscellaneous Outstanding Shares313,860,000Free Float313,575,000Market Cap$284.48 million OptionableNot Optionable Beta0.82 Key ExecutivesMr. Derrick W. West CPA (Age 56)CPA, (CA), Chief Financial Officer Comp: $233.17kMs. Helen Martin (Age 45)Chief Legal Officer & Corp. Sec. Comp: $218.39kMr. Gregory Engel (Age 58)Special Advisor Comp: $436.86kMr. Timothy EmbergChief Revenue OfficerMr. Paolo De Luca C.A. (Age 50)C.F.A, Chief Strategy Officer Comp: $230.09kMs. Beena G. Goldenberg (Age 60)CEO & Director Ms. Nathalie BattenVP of OperationsMr. Geoff RiggsChief Information OfficerAmy SchwalmVP of Investor RelationsMs. Megan Amber McCraeSr. VP of Marketing & CommunicationsMore ExecutivesKey CompetitorsOcular TherapeutixNASDAQ:OCULPharvarisNASDAQ:PHVSBiotech AcquisitionNASDAQ:BIOTAcrivon TherapeuticsNASDAQ:ACRVSavaraNASDAQ:SVRAView All CompetitorsInsiders & InstitutionsETF Managers Group LLCSold 1,451,148 shares on 11/15/2022Ownership: 4.290%Two Sigma Advisers LPSold 155,100 shares on 11/15/2022Ownership: 0.148%Citadel Advisors LLCBought 12,900 shares on 11/15/2022Ownership: 0.000%Marshall Wace LLPBought 43,400 shares on 11/15/2022Ownership: 0.014%Wolverine Trading LLCSold 2,100 shares on 11/14/2022Ownership: 0.000%View All Institutional Transactions OGI Stock - Frequently Asked Questions Should I buy or sell Organigram stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price forecast for 2023? 2 Wall Street analysts have issued twelve-month target prices for Organigram's stock. Their OGI share price forecasts range from $1.50 to $2.00. On average, they expect the company's stock price to reach $1.67 in the next year. This suggests a possible upside of 83.4% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2023? Organigram's stock was trading at $0.80 at the start of the year. Since then, OGI stock has increased by 13.6% and is now trading at $0.9090. View the best growth stocks for 2023 here. Are investors shorting Organigram? Organigram saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 6,170,000 shares, a decline of 17.0% from the December 31st total of 7,430,000 shares. Based on an average trading volume of 1,270,000 shares, the days-to-cover ratio is presently 4.9 days. View Organigram's Short Interest. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 11th 2023. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (NASDAQ:OGI) released its earnings results on Monday, November, 28th. The company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02). The business earned $34.71 million during the quarter, compared to analyst estimates of $32.81 million. Organigram had a negative trailing twelve-month return on equity of 6.00% and a negative net margin of 4.97%. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE). What is Organigram's stock symbol? Organigram trades on the NASDAQ under the ticker symbol "OGI." Who are Organigram's major shareholders? Organigram's stock is owned by a variety of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Organigram? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Organigram's stock price today? One share of OGI stock can currently be purchased for approximately $0.91. How much money does Organigram make? Organigram (NASDAQ:OGI) has a market capitalization of $285.30 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. How many employees does Organigram have? The company employs 841 workers across the globe. How can I contact Organigram? Organigram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726. This page (NASDAQ:OGI) was last updated on 2/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.